BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2023 results, announced a $0.14/share quarterly dividend and provided guidance. Q2 2023 Financial Results Sales $50.1mm, +19% (+16% organic) vs. Q2 2022 Op. income $9.5mm, +63% (+8% adjusted) Op. […]
Financial
Penumbra, Inc. Reports Second Quarter 2023 Financial Results
ALAMEDA, Calif., Aug. 1, 2023 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarter ended June 30, 2023. Revenue of $261.5 million in the second quarter of 2023, an increase of 25.5% as reported and in constant currency1 compared to the second quarter of […]
Silk Road Medical Reports Second Quarter 2023 Financial Results
SUNNYVALE, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2023. “Silk Road is the leading force in stroke prevention for patients with severe […]
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – August 01, 2023
CARLSBAD, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on August 1, 2023 that were approved by the Compensation Committee of its Board of Directors under […]
Esperion Reports Second Quarter 2023 Financial Results
ANN ARBOR, Mich., Aug. 01, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today reported financial results for the second quarter ended June 30, 2023, and provided a business update. “We posted strong results in the second quarter of 2023, reflecting continued prescription growth and an unwavering commitment to execution of […]
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
DUBLIN, Ireland and BRIDGEWATER, N.J. and NANTOU, Taiwan, July 31, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) and Lotus Pharmaceuticals (1795:TT; “Lotus”) today announced that the two companies have entered into a long-term exclusive partnership to distribute and commercialize VAZKEPA® (icosapent ethyl) across 10 countries, including nine in Southeast Asia […]
Society for Vascular Surgery Responds to New York Times Article on Overuse of Interventions in Vascular Surgery
ROSEMONT, Ill., July 31, 2023 /PRNewswire/ — The Society for Vascular Surgery (SVS), the leading medical organization dedicated to advancing quality in vascular health care, has issued a response to a recent New York Times article detailing allegations of overuse of interventions to treat patients with peripheral vascular disease. SVS sent a strong message that it is inaccurate […]
Argon Medical Devices Recognized as 2023 Top Workplace in Manufacturing
PLANO, Texas, July 28, 2023 /PRNewswire/ — Argon Medical Devices, a leading manufacturer of medical devices for interventional procedures, announces recognition as a 2023 Top Workplace in the USA Manufacturing sector. Recipients of the Top Workplaces awards are selected based on feedback from a research-backed employee engagement survey initiated by technology company, Energage. Top […]
RapidAI Announces $75 Million Growth Investment Led by Vista Credit Partners
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced $75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data […]
TransMedics Appoints Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary
ANDOVER, Mass., July 26, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today the appointment of Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary. “We are excited to welcome Anil […]
Recent
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan
CorVista Health Announces Collaboration with Mayo Clinic to Advance Next-Gen Pulmonary Hypertension Diagnosis
Popular
- No commented posts yet